Spots Global Cancer Trial Database for Post-Authorization Long-Term Safety Study of LUTATHERA
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Post-Authorization Long-Term Safety Study of LUTATHERA
Official Title: International, Non-interventional, Post-Authorization Long-Term Safety Study of Lutathera, in Patients With Unresectable or Metastatic, Well-Differentiated, Somatostatin Receptor Positive, Gastroenteropancreatic Neuroendocrine Tumours
Study ID: NCT03691064
Conditions
Interventions
Study Description
Brief Summary: Study to assess the long-term safety of LUTATHERA for the labeled indication (SmPC/USPI).
Detailed Description: To assess the incidence and nature of potential long-term safety outcomes in patients with unresectable or metastatic, well-differentiated, somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours. Retrospective and prospective data will be used.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Banner MD Anderson Cancer Center, Phoenix, Arizona, United States
The Ohio State University Wexner Medical Center, Portland, Ohio, United States
Oregon Health & Sciences University Hospital, Portland, Oregon, United States
Virginia Mason in Seattle, Seattle, Washington, United States
Novartis Investigative site, Clichy, , France
Novartis Investigative site, Lyon, , France
Novartis Investigative site, Villejuif, , France
Novartis Investigative site, Coimbra, , Portugal
Novartis Investigative site, Santiago de Compostela, La Corunya, Spain
Novartis Investigative site, Majadahonda, Madrid, Spain
Novartis Investigative site, Birmingham, , United Kingdom
Novartis Investigative site, Cambridge, , United Kingdom
Novartis Investigative site, Glasgow, , United Kingdom
Novartis Investigative site, Liverpool, , United Kingdom
Novartis Investigative site, London, , United Kingdom
Novartis Investigative site, London, , United Kingdom
Novartis Investigative site, London, , United Kingdom
Novartis Investigative site, London, , United Kingdom
Novartis Investigative site, Manchester, , United Kingdom
Novartis Investigative site, Scheffield, , United Kingdom
Contact Details
Name: Study Director
Affiliation: Advanced Accelerator Applications
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
